venBio Partners — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Impel Neuropharmaimpelneuropharma.comin𝕏Nov 2016SEC filingmedium confidence
HealthtechSeattle, US
John D. Hoekman(Executive Officer, Director)
BoardMichael Hite(Director)Stewart Parker(Director)
Board seatAaron Royston· per SEC Form D · $37.3M raise · filed Dec 2016
Co-investors5AM VenturesB Capital GroupvenBio Global StrategicWestlake Village BioPartners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.